John R. Lowe - Concepedia

Author

John R. Lowe

United States Army Medical Research Institute of Infectious Diseases

Also Known As

J. Lowe, J.R. Lowe, JOHN R. LOWE, John Hok Nin Lowe, John Hok Nin Lowe, John Lowe, John R. Lowe, Lowe,John R

Publications

Citations

H-Index

Concepts

All Affiliations

United States Army Medical Research Institute of Infectious Diseases Bioanalytica (Switzerland)United States Army Ash Stevens (United States)

About

John R. Lowe is an author at United States Army Medical Research Institute of Infectious Diseases specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	725
2	Natural Sciences	4	4	229
3	Allergy	3	3	53
4	Engineering	1	1	20
5	Allergy Medicine	1	1	20

John R. Lowe

Publications

929

Citations

H-Index

Page 1

	Year	Citations
Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo John R. Lowe, James Araujo, Jihong Yang, Experimental Eye Research InflammationAngiogenesisMedicineVascular PharmacologyImmunology	2007	166
Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis Susan L. Welkos, John R. Lowe, F Eden-McCutchan, Gene Protective AntigenNatural SciencesPathogenesisBacteriologyDna Replication	1988	161
Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal anti bodies Stephen F. Little, Jeanne M. Novak, John R. Lowe, Microbiology	1996	127
Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material Saloumeh K Fischer, Melissa Cheu, Kun Peng, The AAPS Journal InflammationHost ResponseAutoimmune DiseasePathogenesisImmunology	2016	112
Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors Hong Xiang, Judith A. Fox, Klára Tótpál, Oncogene Apo2l/trail LigandEnhanced TumorP21 CleavageMedicineApoptosis	2002	50
Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics Deborah Finco, Daniel Baltrukonis, Adrienne Clements‐Egan, Journal of Pharmaceutical and Biomedical Analysis Competitive Ligand-binding AssayMedicineNatural SciencesBioanalysisImmunology	2010	45
Location of receptor-binding region of protective antigen from Bacillusanthracis Stephen F. Little, John R. Lowe Biochemical and Biophysical Research Communications Virulence FactorImmunologyBacteriologyMicrobiologyMedicine	1991	28
Spontaneous and induced reactivation of eel acetylcholinesterase inhibited by three organophosphinates Claire N. Lieske, James H. Clark, Howard G. Meyer, Pesticide Biochemistry and Physiology BiosynthesisEel AcetylcholinesteraseBiochemistryPhysiologyInduced Reactivation	1980	27
The development and assessment of DNA and oligonucleotide probes for the specific detection of <i>Bacillus anthracis</i> Roger A. Hutson, Clive J. Duggleby, John R. Lowe, Journal of Applied Bacteriology	1993	27
Real-time PCR for the early detection and quantification of Coxiella burnetii as an alternative to the murine bioassay Gerald B. Howe, Bonnie M. Loveless, David Norwood, Molecular and Cellular Probes Molecular Diagnostic TechniquesMedicineReal-time PcrBioanalysisPathology	2009	24

Page 1